Bridgett Price
About Bridgett R. Price
Bridgett R. Price, age 67, has served as an independent director of First Advantage Corporation since June 2022 (Class II; term expires at the 2026 annual meeting). She retired from Marriott International in 2023 after a long HR leadership career, including Global Human Resources Officer roles and Chief Human Resources Officer for Europe (2009–2016); she previously served as a Major in the U.S. Air Force. Dr. Price holds a Ph.D. in Educational Leadership and Policy Studies (Arizona State University) and an M.S. in Education and Counseling Psychology (USC) .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Marriott International | Global Human Resources Officer for Consumer, Development, and Operations disciplines | Not disclosed; retired 2023 | Led global HR functions; strategic human capital management |
| Marriott International (Europe) | Chief Human Resources Officer, Europe | 2009–2016 | Regional HR leadership; operations oversight |
| Fortune 500 hospitality and consumer products companies | Various HR executive roles | Not disclosed | Senior human capital roles |
| United States Air Force | Major | Not disclosed | Leadership and operational experience |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| None disclosed | — | — | No current public company directorships disclosed for Dr. Price |
Board Governance
- Independence: The Board affirmatively determined that all directors other than CEO Scott Staples are independent under Nasdaq rules; this includes Dr. Price .
- Committee memberships: Audit Committee member (Chair: Susan R. Bell); Compensation Committee member (Chair: John Rudella). Both committees require enhanced independence standards, which Dr. Price meets .
- Board structure: Classified Board (three classes). Dr. Price is Class II; term expires in 2026 .
- Attendance: In 2024, the Board met 5 times; Audit, Compensation, and Nominating each met 4 times. All directors attended at least 75% of applicable meetings; 5 of 8 directors attended the 2024 annual meeting .
- Executive sessions: Non-management directors meet regularly; independent directors meet privately at least annually (executive sessions presided over by Chairperson Joseph Osnoss) .
- Controlled company: Silver Lake controls a majority of voting power; the company qualifies for Nasdaq’s controlled company exemption but is not currently relying on those exemptions .
Fixed Compensation (Director)
| Component | Amount/Policy | 2024 Value for Dr. Price |
|---|---|---|
| Annual cash retainer (non-Silver Lake directors) | $50,000 (paid quarterly in arrears) | Included in Fees Earned |
| Committee retainers (non-Silver Lake directors) | Audit: Chair $20,000; Member $10,000. Compensation: Chair $15,000; Member $7,500. Nominating: Chair $10,000; Member $5,000 | Included in Fees Earned |
| Fees Earned or Paid in Cash (2024) | Actual cash paid during 2024 | $65,000 |
Performance Compensation (Director Equity)
| Equity Element | Grant/Outstanding | Vesting | 2024 Value |
|---|---|---|---|
| Annual RSU grant (non-Silver Lake directors) | RSUs valued ≈$175,000 each year | 1-year, time-based vesting (no performance conditions) | $174,701 (grant-date fair value for 2024) |
| New director grant at appointment | RSUs ≈$225,000 (three-year vesting) for newly appointed non-Silver Lake directors; Dr. Price received similar grant at appointment (June 17, 2022) | 3-year, time-based vesting | Not applicable to 2024 |
| RSUs outstanding (12/31/2024) | 15,752 RSUs outstanding | Scheduled to vest: 10,672 on June 7, 2025; 5,080 on June 17, 2025 | Not applicable |
Note: Director equity is time-based RSUs; no performance metrics or options are used in non-employee director compensation .
Other Directorships & Interlocks
| Category | Details |
|---|---|
| Current public company boards | None disclosed for Dr. Price |
| Compensation Committee interlocks | None; no member served as a company executive officer in 2024 |
| Silver Lake representation | Three board members are current employees of Silver Lake via stockholders’ agreement nomination rights; Dr. Price is not a Silver Lake employee |
Expertise & Qualifications
- Human capital management and corporate strategy expertise; extensive global HR leadership experience (including Europe CHRO and global HR officer roles) .
- Advanced academic credentials in educational leadership and counseling psychology .
- Military leadership experience (Major, U.S. Air Force) .
- Serves on Audit and Compensation Committees, aligning with HR and governance expertise .
Equity Ownership
| Holder | Shares Beneficially Owned | % of Outstanding | Notes |
|---|---|---|---|
| Bridgett R. Price | 39,252 | <1% | Includes 15,752 RSUs vesting within 60 days of April 24, 2025 |
| Hedging/Pledging policy | — | — | Company policy prohibits hedging and short sales; pledging/margin requires pre-clearance by CLO |
Governance Assessment
-
Strengths
- Independent director with deep HR leadership credentials; active on Audit and Compensation Committees .
- Director compensation balanced between cash fees and annual RSUs; equity fosters alignment, and time-based vesting avoids discretionary performance judgments for directors .
- Formal policies: Incentive compensation clawback (for executives), Securities Trading Policy with hedging/pledging restrictions; robust Related Person Transaction Policy with Audit Committee oversight .
-
Watch items / potential risk indicators
- Controlled company structure with Silver Lake holding 51.6% and broad governance rights; although the company states it is not relying on exemptions, concentrated control can influence board dynamics .
- Classified board (staggered terms) limits immediate shareholder ability to reconstitute the board in any single annual meeting .
- No performance-based elements in director pay; alignment is through time-based RSUs rather than explicit performance metrics (typical but worth noting for pay-for-performance purists) .
-
Engagement/Attendance
- All directors met the 75% attendance threshold in 2024; the Board and its committees met regularly, signaling active oversight. Dr. Price served on two key committees during that period .
-
Compensation committee governance
- Uses independent consultant Pearl Meyer; the Compensation Committee reported no conflicts with the consultant in 2024 .
Overall, Bridgett R. Price appears to be a qualified, independent director with relevant HR and organizational leadership expertise, actively engaged through Audit and Compensation committee service, and with equity ownership that aligns incentives. The principal governance considerations relate to FA’s controlled-company status and classified board structure, rather than any individual concerns about Dr. Price .